/Investor DB

Sahsen Ventures — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Synthesizesynthesize.bioinSep 2025 · $10M

Synthesize develops generative AI models that simulate human tissue responses to drugs and diseases for clinical trial design.

AI & Machine LearningBiotechDigital Health

Robert Bradley, PhDinJeff Leek, PhDinAlice Walsh, PhDinGregory Koytiger, PhDinJeff Leek(Founder)Robert Bradley(Founder)

Co-investorsMadrona Venture GroupAI2 IncubatorInner Loop Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.